Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.09 by 66.67 percent. This is a 86.36 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $821.821 million which missed the analyst consensus estimate of $866.120 million by 5.11 percent. This is a 17.49 percent decrease over sales of $996.000 million the same period last year.